PTSD has been around for a long time, as humankind has grappled with the environment and other humans. But the experiences of the military in recent wars again bring it to the fore. And disasters like the Gulf oil spill remind us that PTSD can affect anyone. We take a brief look at post-traumatic stress disorder, as a form of memory not unlike an acid flashback, and new avenues of therapies, including the use of ecstacy (MDMA).
Archive for the ‘Understanding Addictions & Brain Chemistry’ Category
Post-Traumatic Stress Disorder & Ecstacy
Thursday, July 29th, 2010New treatment for uppers, and changes in federal funding
Wednesday, July 14th, 2010No treatment medications for cocaine and meth addicts have been approved by the FDA. Now a new drug that focuses on upper drugs – in combination with motivational counseling – is being clinically tested in San Francisco that may offer cocaine and meth users more hope for better treatment outcomes from their addiction. Also a look at what defines a federally-qualified behavioral health center, and the hope for more treatment options. Dr Inaba comments.
Advances in addiction treatment medications
Thursday, June 24th, 2010As our understanding of the reward-reinforcement systems and other brain functions increases, more medications are being developed for the treatment of addictions – naltrexone and buprenorphine for opiods, bupropion for tobacco and others. And they hold promise for help with more than just drug addiction. Dr Inaba comments.
Addicted to gizmos
Thursday, June 17th, 2010As the pre-orders for the new iPhone 4 overwhelm AT&T computers and generate the latest buzz for Apple, we take a look at our modern fascination — or is it our newest addiction — with the myriad hi-tech gizmos that surround us. Dr Inaba looks at the comparison.






